Vincera Pharma, Inc.(VINC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

VINC Vincera Pharma, Inc.

Closed Good Friday 04-17 16:00:00 EDT

0.2750

+0.0000

0.00%

High0.2750	Low0.2750	Vol0.00
Open0.2750	D1 Closing0.2750	Amplitude0.00%
Mkt Cap1.44M	Tradable Cap1.36M	Total Shares5.23M
T/O0.00	T/O Rate0.00%	Tradable Shares4.94M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"VINC","market":"US","secType":"STK","nameCN":"Vincera Pharma, Inc.","latestPrice":0.275,"timestamp":1744920000000,"preClose":0.275,"halted":0,"volume":0,"delay":0,"floatShares":4940480,"shares":5234277,"eps":-15.8451,"marketStatus":"Closed Good Friday","change":0,"latestTime":"04-17 16:00:00 EDT","open":0.275,"high":0.275,"low":0.275,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-15.8451,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.275,"volumeRatio":0},"requestUrl":"/m/hq/s/VINC","defaultTab":"news","newsList":[{"id":"2528016779","title":"BRIEF-Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=2528016779","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528016779?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 05:28","pubTimestamp":1744925291,"startTime":"0","endTime":"0","summary":"BRIEF-Vincerx Pharma Announces Intent To Delist From NasdaqAnd Deregister With The SECApril 17 (Reuters) - Vincerx Pharma Inc VINC.O:VINCERX PHARMA, INC. ANNOUNCES INTENT TO DELIST FROM NASDAQ AND DER","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA4H4L9N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VINC"],"gpt_icon":0},{"id":"2528795347","title":"Vincerx Pharma Plans Delisting After Nasdaq Suspends Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2528795347","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528795347?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 05:07","pubTimestamp":1744924071,"startTime":"0","endTime":"0","summary":"Vincerx Pharma  said late Thursday it plans to file a delisting form with the Securities and Exchange Commission on or about April 28 to have its common stock removed from Nasdaq.The decision comes after Vincerx was issued a noncompliance notice from Nasdaq for failing to meet the minimum $1.00 bid price requirement for 30 consecutive business days without any period to regain compliance, the company said.Nasdaq suspended trading of the company's common shares on April 16 despite notifying it would do so on April 23, it added.Vincerx said it worked with Nasdaq to allow trading to resume on Monday, and trading will be permanently suspended at the open of business on April 23.The company said it will file Form 15 to deregister with the SEC once the delisting application comes into effect.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NQmain","IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4112","BK4139",".IXIC","BK4585","BK4588","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210150020.SGD","LU2210149790.SGD","LU2095319765.USD","VINC","NDAQ"],"gpt_icon":0},{"id":"2528764637","title":"Vincerx Pharma announces plan to delist from Nasdaq","url":"https://stock-news.laohu8.com/highlight/detail?id=2528764637","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528764637?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 04:50","pubTimestamp":1744923010,"startTime":"0","endTime":"0","summary":"Vincerx Pharma (VINC) announced its intention to file a Form 25 Notification of Delisting with the SEC on or about April 28, which will remove Vinc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vincerx-pharma-announces-plan-to-delist-from-nasdaq?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vincerx-pharma-announces-plan-to-delist-from-nasdaq?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B64PRP62.GBP","QID","SQQQ","NDAQ","LU2210149790.SGD","VINC","BK4585","MNQmain","BK4139","IE00BKPKM429.USD","TQQQ","BK4588","BK4112","LU2095319765.USD","QLD","NVIW.SI","LU2210150020.SGD","PSQ","TSYW.SI","USJW.SI","IE00B3QW5Z07.USD","NQmain",".IXIC","USAW.SI","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2528776633","title":"Vincerx Pharma, Inc. Announces Intent to Delist From Nasdaq and Deregister With the SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=2528776633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528776633?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 04:45","pubTimestamp":1744922700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA4H4L9N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VINC"],"gpt_icon":0},{"id":"2528766387","title":"Vincerx Pharma Inc - Stock to Resume Trading on April 21, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2528766387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528766387?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 04:45","pubTimestamp":1744922700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA4H4L9N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VINC","BK4139"],"gpt_icon":0},{"id":"2528766347","title":"Vincerx Pharma Inc - Board Decides to Dissolve, Liquidate, and Wind-up Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2528766347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528766347?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 04:45","pubTimestamp":1744922700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA4H4L9N:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VINC"],"gpt_icon":0},{"id":"2528776093","title":"Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=2528776093","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528776093?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 04:45","pubTimestamp":1744922700,"startTime":"0","endTime":"0","summary":"Vincerx common stock suspended by Nasdaq inadvertently; will resume trading at the open of business on April 21, 2025. Trading to be permanently suspended by Nasdaq at the open of business on April 23, 2025. Forward-Looking InformationThis press release contains forward-looking statements within the meaning of the federal securities laws including, but not limited to, statements about: Vincerx’s intent to file a Form 25 and Form 15 with the SEC and the expected timing thereof; Vincerx’s intent not to appeal Nasdaq’s determination and not to list its common stock on another national securities exchange or other market; and expectations with respect to the resuming and suspension of trading of Vincerx’s common stock on Nasdaq. Forward-looking statements involve risks and uncertainties that may cause actual results or performance to differ materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, bu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vincerx-pharma-inc-announces-intent-204500865.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B64PRP62.GBP","QID","SQQQ","NDAQ","LU2210149790.SGD","VINC","BK4585","MNQmain","BK4139","IE00BKPKM429.USD","TQQQ","BK4588","BK4112","LU2095319765.USD","QLD","NVIW.SI","LU2210150020.SGD","PSQ","TSYW.SI","USJW.SI","IE00B3QW5Z07.USD","NQmain",".IXIC","USAW.SI","IE00BGHQF748.EUR"],"gpt_icon":1},{"id":"2526539428","title":"Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2526539428","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526539428?lang=en_us&edition=full_marsco","pubTime":"2025-04-10 00:06","pubTimestamp":1744214792,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/04/44717350/crude-oil-down-4-neogen-shares-plunge-after-q3-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU1642822529.SGD","PHIO",".IXIC","SMPL","BK4541","BK4082","LU1815336760.USD","BK4139","TSYW.SI","VINC","NQmain","LU2357125470.USD","LU0823414478.USD","USAW.SI","TQQQ","QLD","BK4075","BK4182","PSQ","LU0444971666.USD","LU2249611893.SGD","USJW.SI","QID","NEOG","LU2211817866.USD","XXII","BK4212","SQQQ","VERO","LU2506951792.HKD","NVIW.SI","MNQmain","LU0476273544.USD","LU0957808578.USD","BK4198","LU0444973449.USD","BE","LU0823414551.USD","LU2294711713.HKD","BK4588"],"gpt_icon":1},{"id":"2526828965","title":"Vincerx Pharma Begins Wind-Down After Terminating Merger Plan With QumulusAI","url":"https://stock-news.laohu8.com/highlight/detail?id=2526828965","media":"MT Newswires Live","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526828965?lang=en_us&edition=full_marsco","pubTime":"2025-04-09 04:26","pubTimestamp":1744144014,"startTime":"0","endTime":"0","summary":"Vincerx Pharma  started shutdown measures after terminating its nonbinding letter of intent for a potential merger with Global Digital Holdings, operating as QumulusAI.The board \"authorized management to initiate wind-down activities and continue exploring monetization of assets and out-licensing opportunities,\" Vincerx said Tuesday in a statement.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00999","VINC","BK4139","BK1233"],"gpt_icon":0},{"id":"2526282895","title":"Vincerx Terminates Merger Attempt, Initiates Wind-Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2526282895","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526282895?lang=en_us&edition=full_marsco","pubTime":"2025-04-09 04:26","pubTimestamp":1744143960,"startTime":"0","endTime":"0","summary":"Vincerx has terminated its previously announced intent to merge with Global Digital Holdings and is now winding down operations.The clinical-stage biopharmaceutical company said Tuesday its board has authorized management to initiate a wind-down and continue exploring monetization of assets and out-licensing opportunities.Acting Chief Executive Raquel Izumi said unprecedented, adverse market dynamics prevented the company from continuing the developments of its programs.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Vincerx Terminates Merger Attempt, Initiates Wind-Down","news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VINC"],"gpt_icon":0},{"id":"2526840425","title":"BRIEF-Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2526840425","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526840425?lang=en_us&edition=full_marsco","pubTime":"2025-04-09 04:11","pubTimestamp":1744143073,"startTime":"0","endTime":"0","summary":"BRIEF-Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down ActivitiesVincerx Pharma Inc VINC.O:VINCERX PHARMA ANNOUNCES TERMINATION OF LETTER OF INTENT ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUA9WB30N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VINC"],"gpt_icon":0},{"id":"2526840956","title":"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2526840956","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526840956?lang=en_us&edition=full_marsco","pubTime":"2025-04-09 04:05","pubTimestamp":1744142700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUA9WB30N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VINC"],"gpt_icon":0},{"id":"2526384094","title":"Vincerx Pharma - Board Authorizes to Continue Asset Monetization & Out-Licensing Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2526384094","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526384094?lang=en_us&edition=full_marsco","pubTime":"2025-04-09 04:05","pubTimestamp":1744142700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUA9WB30N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VINC"],"gpt_icon":0},{"id":"2526984840","title":"Press Release: Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2526984840","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526984840?lang=en_us&edition=full_marsco","pubTime":"2025-04-09 04:05","pubTimestamp":1744142700,"startTime":"0","endTime":"0","summary":"Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities. SAN MATEO, Calif., April 08, 2025  -- Vincerx Pharma, Inc.  today announced that it has terminated the previously announced non-binding Letter of Intent  with Global Digital Holdings Inc., conducting business as QumulusAI, regarding a potential merger.Actual results, conditions, and events may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results, conditions, and events to differ materially from those indicated in the forward-looking statements include, but are not limited to: availability and sufficiency of cash to complete an orderly wind-down of the Company's business; the Company's ability to out-license or otherwise monetize its assets and intellectual property and the amount of cash, if any, received from such activities; the ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VINC"],"gpt_icon":0},{"id":"2522554726","title":"Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522554726","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522554726?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 08:08","pubTimestamp":1743120489,"startTime":"0","endTime":"0","summary":"Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings SummaryVincerx Pharma Inc VINC.OQ reported a quarterly adjusted loss of $4.20 per share for the quarter ended December 3","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL5N3QB00D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VINC"],"gpt_icon":0},{"id":"2522029998","title":"Vincerx Pharma Inc  expected to post a loss of $3.40 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2522029998","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522029998?lang=en_us&edition=full_marsco","pubTime":"2025-03-25 19:35","pubTimestamp":1742902516,"startTime":"0","endTime":"0","summary":"Vincerx Pharma Inc  expected to post a loss of $3.40 a share - Earnings Preview Vincerx Pharma Inc VINC.OQ VINC.O is expected to show no change in quarterly revenue when it reports  results on March 2","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL5N3Q80RH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VINC"],"gpt_icon":0},{"id":"2520760530","title":"BUZZ-Vincerx Pharma soars on QumulusAI merger deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2520760530","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520760530?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 22:14","pubTimestamp":1742307246,"startTime":"0","endTime":"0","summary":"BUZZ-Vincerx Pharma soars on QumulusAI merger deal** Shares of drug developer Vincerx Pharma VINC.O rise as much as 47% to $1.22** VINC is planning to merge with QumulusAI, a private company that provides high-performance computing infrastructure for AI, the companies say** The planned merger would make QumulusAI a publicly traded company; QumulusAI shareholders would own about 95% of the combined company, while VINC shareholders would own the rest** Proposed deal values QumulusAI at around $285 million and Vincerx at around $15 million** Following close of deal, QumulusAI would have a say on the combined company's management team and board of directors** Stock fell 77.7% in 2024  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nL4N3Q1123:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VINC"],"gpt_icon":0},{"id":"2520605778","title":"Vincerx Pharma Plans Reverse Merger With AI Infrastructure Firm QumulusAI","url":"https://stock-news.laohu8.com/highlight/detail?id=2520605778","media":"MT Newswires","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520605778?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 21:39","pubTimestamp":1742305166,"startTime":"0","endTime":"0","summary":"Vincerx Pharma  said Tuesday it has entered into a nonbinding letter of intent for a reverse triangular merger that would result in artificial intelligence infrastructure company Global Digital, doing business as QumulusAI, becoming a publicly traded company.The proposed transaction values QumulusAI at about $285 million and Vincerx at around $15 million, Vincerx said.Under the proposed terms, Vincerx said its subsidiary would merge into QumulusAI, with QumulusAI stockholders receiving Vincerx shares. QumulusAI options, warrants, and other rights would be converted into options, warrants, and rights to acquire Vincerx stock.As part of the deal, QumulusAI or its designees will also invest up to $1.5 million in Vincerx before the transaction closes, according to Vincerx.QumulusAI shareholders are expected to own about 95% of the combined company, with Vincerx holders holding the remaining 5%, Vincerx said.The companies have agreed to a 30-day exclusivity period to negotiate and sign a de","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vincerx-pharma-plans-reverse-merger-133926968.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VINC","BK4139"],"gpt_icon":0},{"id":"2520674546","title":"Vincerx Pharma : as of Feb 28, 2025, Had About$3.9 Mln in Cash and Anticipates Its Cash Runway Will Extend Into Late Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520674546","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520674546?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 21:13","pubTimestamp":1742303596,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q115X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VINC"],"gpt_icon":0},{"id":"2520676083","title":"Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination With Qumulusai","url":"https://stock-news.laohu8.com/highlight/detail?id=2520676083","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520676083?lang=en_us&edition=full_marsco","pubTime":"2025-03-18 20:52","pubTimestamp":1742302376,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nTUAJQMQN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VINC","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vincerx.com","stockEarnings":[{"period":"1week","weight":0.0492},{"period":"1month","weight":-0.6176},{"period":"3month","weight":-0.9097},{"period":"6month","weight":-0.9638},{"period":"1year","weight":-0.9855},{"period":"ytd","weight":-0.9477}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. It is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with hematologic malignancies; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat solid tumors. The company's preclinical stage product candidates include VIP943 and VIP924 for the treatment of hematologic malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.098055},{"month":2,"riseRate":0.4,"avgChangeRate":0.207365},{"month":3,"riseRate":0.2,"avgChangeRate":-0.095894},{"month":4,"riseRate":0.2,"avgChangeRate":-0.316695},{"month":5,"riseRate":0.25,"avgChangeRate":-0.081376},{"month":6,"riseRate":0.2,"avgChangeRate":-0.067243},{"month":7,"riseRate":0.6,"avgChangeRate":-0.056825},{"month":8,"riseRate":0.6,"avgChangeRate":0.031662},{"month":9,"riseRate":0.6,"avgChangeRate":0.11529},{"month":10,"riseRate":0.2,"avgChangeRate":-0.141886},{"month":11,"riseRate":0.2,"avgChangeRate":-0.201991},{"month":12,"riseRate":0.6,"avgChangeRate":0.286791}],"exchange":"NASDAQ","name":"Vincera Pharma, Inc.","nameEN":"Vincera Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vincera Pharma, Inc.(VINC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Vincera Pharma, Inc.(VINC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Vincera Pharma, Inc.,VINC,Vincera Pharma, Inc.股票,Vincera Pharma, Inc.股票老虎,Vincera Pharma, Inc.股票老虎国际,Vincera Pharma, Inc.行情,Vincera Pharma, Inc.股票行情,Vincera Pharma, Inc.股价,Vincera Pharma, Inc.股市,Vincera Pharma, Inc.股票价格,Vincera Pharma, Inc.股票交易,Vincera Pharma, Inc.股票购买,Vincera Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vincera Pharma, Inc.(VINC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Vincera Pharma, Inc.(VINC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction